Dina Popova

Dina Popova

Auto-generated profile, based on publicly available information

Dina Popova

Human Genetics Institute, Rutgers University

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
DPDina Popova
Dina Popova
AÁArna Ágústsdóttir
Arna Ágústsdóttir
JLJesse Lindholm
Jesse Lindholm
UMUlams Mazulis
Ulams Mazulis
YAYumiko Akamine
Yumiko Akamine
NKNina N. Karpova
Nina N. Karpova

24 January 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
FMFulin Ma
Fulin Ma
JXJianquan Xu
Jianquan Xu
YLYang Liu
Yang Liu
DPDina Popova
Dina Popova
MYMark M. Youssef
Mark M. Youssef
KHKarl Herrup
Karl Herrup
The small Aβ peptide has been hypothesized to be the main driver of Alzheimer’s disease (AD). Aβ is a proteolytic cleavage product of a larger protein, the amyloid precursor protein (APP), whose normal functions remain largely unexplored. We report here activities of the full-length APP protein that relate directly to the etiology of AD. Increasing neuronal activity leads to a rapid increase in App gene expression. In both cultures of mouse cortical neurons and human iPSC-derived neurons, elevated APP protein changes the structure of the axon initial segment (AIS), the site of action potential initiation. In neurons with elevated APP, the AIS shortens in length and shifts in position away from the cell body. Both changes would be expected to reduce neuronal excitability. The AIS effects are due to the cell-autonomous actions of APP; exogenous Aβ – either fibrillar or oligomeric – has no effect. The findings relate directly to AD in several ways. In culture, APP carrying the Swedish familial AD mutation (APP Swe ) induces stronger AIS changes than wild type APP. Ankyrin G and βIV-spectrin, scaffolding proteins of the AIS, both physically associate with APP, and APP Swe binds more avidly than wild type APP. Finally, neurons in the frontal cortex of humans with sporadic AD reveal histologically elevated levels of APP protein that invade the domain of the AIS, whose length is significantly shorter than that found in healthy control neurons. The findings offer an alternative explanation for the effects of at least some familial AD mutations. Significance: In familial Alzheimer’s disease (AD) the linkage between the genetics of APP, the neuropathology of the amyloid plaques and the symptoms of dementia are one of the strongest pieces of evidence supporting the amyloid cascade hypothesis – a conceptualization that marks the Aβ peptide as the root cause of AD. Yet, formally, the genetics only point to APP, not its Aβ breakdown product. We report here that the full-length APP protein affects the properties of the axon initial segment and through these changes serves as a dynamic regulator of neuronal activity. We propose that this newly discovered APP function offers a different, Aβ-independent, view of the genetic evidence.

18 June 2020 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
AHApoorva Halikere
Apoorva Halikere
DPDina Popova
Dina Popova
MSMatthew S. Scarnati
Matthew S. Scarnati
AHAula Hamod
Aula Hamod
MSMavis R. Swerdel
Mavis R. Swerdel
ZPZhiping P. Pang
Zhiping P. Pang

24 May 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
DPDina Popova
Dina Popova
IGIsabel Gameiro-Ros
Isabel Gameiro-Ros
MYMark M. Youssef
Mark M. Youssef
PZPetronio Zalamea
Petronio Zalamea
AMAyeshia D. Morris
Ayeshia D. Morris
RHRonald Hart
Ronald Hart
Synonymous and noncoding single nucleotide polymorphisms (SNPs) in the KCNJ6 gene, encoding G protein-gated inwardly rectifying potassium (GIRK2) channel subunit 2, have been linked with increased electroencephalographic frontal theta event-related oscillations (ERO) in subjects diagnosed with alcohol use disorder (AUD). To identify molecular and cellular mechanisms while retaining the appropriate genetic background, we generated induced excitatory glutamatergic neurons (iN) from iPSCs derived from four AUD-diagnosed subjects with KCNJ6 variants (‘Affected: AF’) and four control subjects without variants (‘Unaffected: UN’). Neurons were analyzed for changes in gene expression, morphology, excitability and physiological properties. Single cell RNA sequencing suggests that KCNJ6 AF variant neurons have altered patterns of synaptic transmission and cell projection morphogenesis. Results confirm that AF neurons express lower levels of GIRK2, have greater neurite area, and elevated excitability. Interestingly, exposure to intoxicating concentrations of ethanol induces GIRK2 expression and reverses functional effects in AF neurons. Ectopic overexpression of GIRK2 alone mimics the effect of ethanol to normalize induced excitability. We conclude that KCNJ6 variants decrease GIRK2 expression and increase excitability and that this effect can be minimized or reduced with ethanol.